Renal protective effect of dexmedetomidine in children undergoing cardiac surgery: A randomoized controlled study

dexmedtomidine and kidney function in children after cardiac surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201801003000154

Enrollment

100

Registered

2018-01-22

Start date

2018-02-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury, Occupational Diseases, Poisoning Paediatrics kidney function during and after pediatric cardiac surgery Kidney Disease

Interventions

dexmedtomidine

saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: any child below 18 years that undergo cardiac surgery

Exclusion criteria

Exclusion criteria: known allergy to dexmedetomidine, congestive heart failure, renal impairment, liver diseases, coagulation disorders, permanent pacemaker, history of preoperative bradyarrhythmias,diabetes

Design outcomes

Primary

Measure	Time frame
incidence of acute renal injury	—

Secondary

Measure	Time frame
side effects of the drug, duration of mechanical ventilation, ICU stay, hospital stay, and mortality.	—

Countries

Egypt

Contacts

Public ContactNagat Elshmaa

associate professor of anesthesiology

nagat_elshmaa@yahoo.com00201279999697

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026